Guaifenesin
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162727This classification denotes an expectorant with the molecular formula C10H14O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears US NIH Compound Identifier 3516. European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification. GUAIFENESIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule guaifenesin under HS 29094990 and SITC 51617. As of Q4 2014, GUAIFENESIN remains US FDA's Preferred Term for this commodity. Guaifenesin bears US NLM identifiers UMLS ID C0018305 and NCI Concept Code C29081. SMILES: COC1=CC=CC=C1OCC(CO)O.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.